ArticleCancer management and research2026
AC067930.4/miR-375 Axis Regulates the Malignant Progression of Colon Adenocarcinoma Through the Cuproptosis-Related Gene
Article in Cancer management and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Colon adenocarcinoma (COAD) is associated with high incidence rates and poor prognosis. LncRNAs and microRNAs are known to regulate COAD progression via the competing endogenous RNA (ceRNA) mechanism. Cuproptosis has emerged as a significant factor in COAD cell death regulation and therapeutic responses. However, the ceRNA network related to cuproptosis within COAD has yet to be fully clarified. Methods: Differential expression analysis and phenotypic experiments were conducted. Luciferase reporter assays and rescue experiments were performed to elucidate mechanisms. Results: The AC067930.4/miR-375 axis was found to drive SLC6A6, promoting COAD malignant progression. Suppressing SLC6A6 induced cuproptosis by modulating copper ion levels and ROS. The AC067930.4/miR-375/SLC6A6 axis regulated cell proliferation, migration, and apoptosis. Mechanistically, AC067930.4 functioned as a ceRNA for miR-375 to regulate SLC6A6 expression. Rescue experiments demonstrated that miR-375's regulatory role in COAD malignant progression was partly dependent on SLC6A6. Conclusion: Our research elucidates a cuproptosis-related ceRNA regulatory network and offers novel potential targets for COAD diagnosis and therapy of COAD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.